Variables | Total cohort (n = 147) | Propensity-matched cohort (n = 70) | ||||
---|---|---|---|---|---|---|
TAR | Hybrid | P value | TAR | Hybrid | P value | |
(n = 142) | (n = 35) | (n = 35) | (n = 35) | |||
ICU time (d) | 7.4 ± 2.0 | 2.8 ± 1.0 | < 0.001 | 6.8 ± 2.1 | 2.8 ± 1.4 | < 0.001 |
Ventilation time(h) | 63.5 ± 19.7 | 18.5 ± 9.2 | < 0.001 | 59.7 ± 21.2 | 18.5 ± 9.2 | < 0.001 |
Hospital stay time(d) | 17.9 ± 4.7 | 12.3 ± 4.3 | < 0.001 | 19.5 ± 6.4 | 12.3 ± 4.3 | < 0.001 |
Erythrocyte volume(u) | 6.6 ± 2.4 | 4.2 ± 0.7 | < 0.001 | 4.5 ± 3.1 | 4.2 ± 0.7 | 0.103 |
Plasma volume(ml) | 511.3 ± 190.1 | 420.0 ± 211.2 | 0.027 | 421 ± 152.1 | 420.0 ± 211.2 | 0.512 |
Pulmonary infection, n (%) | 21 (29.6) | 4 (11.4) | 0.038 | 7 (20.0) | 4 (11.4) | 0.328 |
Renal dysfunction, n (%) | 10 (14.1) | 3 (8.57) | 0.416 | 6 (17.1) | 3 (8.57) | 0.912 |
TND, n (%) | 19 (26.8) | 3 (8.6) | 0.03 | 3 (8.6) | 3 (8.6) | 1 |
PND, n (%) | 4 (5.6) | 0 | 0.152 | 3 (8.6) | 0 | 0.752 |
30-Day mortality, n (%) | 6 (8.5) | 1 (2.9) | 0.268 | 4 (11.4) | 1 (2.9) | 0.738 |